International Journal of Cardiology
Volume 131, Issue 2 , Pages 186-191 , 9 January 2009

Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy

Received 23 December 2006 ,Revised 20 August 2007 ,Accepted 20 October 2007.

References 

  1. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509–516
  2. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel hormone in human. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402–1412
  3. Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin N Am. 1995;24:481–509
  4. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with heart failure. Circulation. 2000;102:3060–3067
  5. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the VESnarinone Trial (VEST). Circulation. 2001;103:2055–2059
  6. Mattei MG, Borg JP, Rosnet O, Marme D, Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics. 1996;32:168–169
  7. Autiero M, Luttun A, Tjwa M, Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost. 2003;1:1356–1370
  8. Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831–840
  9. Heeschen C, Dimmeler S, Fichtlscherer S, et al. for the CAPTURE Investigators Prognostic value of placental growth factor in patients with acute chest pain. JAMA. 2004;291:435–441
  10. Lenderink T, Heeschen C, Fichtlscherer S, et al. for the CAPTURE Investigators Elevated placental growth factor levels are associated with adverse outcome at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol. 2006;47:307–311
  11. Matsumori A, Furukawa Y, Hashimoto T, et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun. 1996;221:391–395
  12. Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 2000;35:968–973
  13. Abraham D, Hofbauer R, Schafer R, et al. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res. 2000;87:644–647
  14. Taniyama Y, Morishita R, Aoki M, et al. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension. 2002;40:47–53
  15. Li Y, Takemura G, Kosai K, et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation. 2003;107:2499–2506
  16. Lamblin N, Susen S, Dagorn J, et al. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J. 2005;150:137–143
  17. Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GYH. Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol. 2002;90:1258–1260
  18. Green CJ, Lichtlen P, Huynh NT, et al. Placental growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res. 2001;61:2696–2703
  19. Khaliq A, Dunk C, Jiang J, et al. Hypoxia downregulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for “placental hyperoxia” in intrauterine growth restriction. Lab Invest. 1999;79:151–170
  20. Cao Y, Linden P, Shima D, Browne F, Folkman J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest. 1996;98:2507–2511
  21. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR 1(+) stem cell from bone-marrow microenvironment. Nat Med. 2002;8:841–849
  22. Iwama H, Uemura S, Naya N, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;47:1559–1567
  23. Lamblin N, Mouquet M, Hennache B, et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J. 2005;26:2245–2250

☆ There is not any financial association that might pose any potential conflict of interest to disclose.

PII: S0167-5273(07)01950-X

doi: 10.1016/j.ijcard.2007.10.050

International Journal of Cardiology
Volume 131, Issue 2 , Pages 186-191 , 9 January 2009

Article Tools

* Image Usage & Resolution